A PRMT5 inhibitor protects against noise-induced hearing loss by alleviating ROS accumulation

Ecotoxicol Environ Saf. 2022 Sep 15:243:113992. doi: 10.1016/j.ecoenv.2022.113992. Epub 2022 Aug 19.

Abstract

The aim of this study was to investigate the effect of LLY-283, a selective inhibitor of protein arginine methyltransferase 5 (PRMT5), on a noise-induced hearing loss (NIHL) mouse model and to identify a potential target for a therapeutic intervention against NIHL. Eight-week-old male C57BL/6 mice were used. The auditory brainstem response was measured 2 days after noise exposure. The apoptosis of hair cells (HCs) was detected by caspase-3/7 staining, whereas the accumulation of reactive oxygen species (ROS) was measured by 4-HNE staining. We demonstrated that the death of HCs and loss of cochlear synaptic ribbons induced by noise exposure could be significantly reduced by the presence of LLY-283. LLY-283 pretreatment before noise exposure notably decreased 4-HNE and caspase-3/7 levels in the cochlear HCs. We also noticed that the number of spiral ganglion neurons (SGNs) was notably increased after LLY-283 pretreatment. Furthermore, we showed that LLY-283 could increase the expression level of p-AKT in the SGNs. The underlying mechanism involves alleviation of ROS accumulation and activation of the PI3K/AKT pathway, indicating that LLY-283 might be a potential candidate for therapeutic intervention against NIHL.

Keywords: Hair cell; NIHL; PRMT5; Reactive oxygen species; Spiral ganglion neurons.

MeSH terms

  • Animals
  • Caspase 3
  • Enzyme Inhibitors / therapeutic use
  • Hearing Loss, Noise-Induced* / drug therapy
  • Hearing Loss, Noise-Induced* / metabolism
  • Hearing Loss, Noise-Induced* / prevention & control
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Reactive Oxygen Species

Substances

  • Enzyme Inhibitors
  • Reactive Oxygen Species
  • Proto-Oncogene Proteins c-akt
  • Caspase 3